The Singapore Israel Industrial R&D Foundation

Shulov Institute for Science Ltd. (S.I.S)

Shulov Institute for Science Ltd. (S.I.S)

Company: Shulov Institute for Science Ltd. (S.I.S)
Name: Eran Lazar
Designation: -
Country: Israel
Address: -
Tel: +972 8 9314114
Mobile: -
Fax: +972 8 9314114
Technology Classification: Drugs Development
Main Business Activity: A novel bio-pharmaceutical (anti-viral) substance formulated as a cream for topical application directly on the skin to treat various skin disorders, such as HSV1 induced clinical symptoms.

Company Profile, Products & Technologies, Target Market:

S.I.S was founded in 1985 by Mr. Aviv Marx and Prof. Aharon Shulov who was Professor of Zoology at the world-famous Hebrew University of Jerusalem. The company is focused in development of human therapeutics derived from snake venom. The company has more than 25 years of R&D research experience in the area of chronic pain. During this period the company has isolated from the total mixture of the viper snake venom a novel non-toxic active analgesic tetra peptide. These pre-clinical results were the basis for the current idea of formulating a solution for the herpes virus.

Brief description of proposed R&D project:

The purpose of the current co-operation is to develop a novel product, a novel synthetic tetra peptide formulated as a cream for topical application on the skin to treat various skin disorders, such as Herpes Simplex Virus 1 (HSV1) induced clinical symptoms. Prepare an IND file for Phase I clinical study based on the accumulated safety toxicology data, submit the file and perform the Phase I study.

Topical application of the cream twice a day eliminates pain within few minutes and prevents swelling and lesion formation within 36 hours in a mouse model that mimics the clinical symptoms induced by HSV1 infection.

Desired Profile of R&D Partner and its role in the proposed project:

The Israeli company motivation is to co-operate with an experienced company who can meet the safety tests, thus an IND file will be submitted in 24 months to the regulatory authority. This company should have the required labs for such an R&D activity.

R&D Partner Search

SIIRD promotes, facilitates and funds joint industrial R&D collaboration between Singapore-based companies and Israel-based companies.

R&D Partner Search Request Form

Please complete the 'R&D Partner Search Request Form' if your company is interested to search for technology partner in Singapore or Israel for joint R&D collaboration.

Our offices in Singapore and Israel will attempt to do a matching and make initial contact with any company which might be of interest to you.

The form will only be used for the purpose of matching potential R&D collaboration partners in Singapore and Israel under the SIIRD programme.

Companies who have been matched and who would like to jointly apply for funding for research and development  activities can do so by following the instructions in the  Proposal Submission page.

Alternatively, companies can refer to the lists of companies from Singapore and Israel who have indicated interest to look for R&D partners. Please contact the SIIRD Management if you have identified suitable partners from the lists and we will link you up with the relevant parties. Please refer to the hyperlinks above for access to the lists.

"The SIIRD mechanism provides a unique blend of funding to defray R&D costs and partnership with Israeli companies. The partnership with CET in Israel created immense synergy through their deep knowledge, experience, and enthusiasm.  For these reasons, SIIRD has a unique value proposition that is difficult to replicate even using other government funding mechanisms."
- Dr. Ori Sasson, CEO
Dynamics Speech Pte Ltd